Kangabio

Shanghai, China · Founded 2021 · Privately Held (backing)

Researcher and developer of drugs intend to serve the pharmaceutical industry. Kangabio is based in Shanghai, China and was founded in 2021. It has raised $29.9 million.

Last price · $/share
—
Implied valuation
—
Total raised
$29.9M
Last round
—

Who backs Kangabio?

4 investors
InvestorType
Teda VCOther
Taikun FundOther
BOHE Angel Fund—
Daoyuan Capital—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Kangabio investors

4 investors are on record for Kangabio, including Teda VC, Taikun Fund, BOHE Angel Fund and Daoyuan Capital.

Free account
More of Kangabio with a free account
  • ·Watch Kangabio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 4 firms already write checks for companies like Kangabio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View